Inhibition of Hsp90: A Multitarget Approach to Radiosensitization
- 1 August 2007
- journal article
- review article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 13 (15), 4326-4330
- https://doi.org/10.1158/1078-0432.ccr-07-0632
Abstract
Hsp90, the 90 kDa heat shock protein, is a highly expressed molecular chaperone that modulates the stability and/or transport of a diverse set of critical cellular regulatory proteins. Among Hsp90 clients are a number of proteins, which in a cell type–dependent manner, contribute to tumor cell radioresistance. Exposure of a variety of solid tumor cell lines to clinically relevant Hsp90 inhibitors results in the simultaneous loss of these radioresponse-associated proteins, which is accompanied by an increase in radiosensitivity. This radiosensitization has been linked to a compromise in the DNA damage response to radiation including the inhibition of cell cycle checkpoint activation and DNA double-strand break repair. With respect to potential clinical application, the expression of ErbB3 seems to predict tumor cells that are resistant to the effects of Hsp90 inhibition on radiosensitivity. Moreover, whereas an increase in tumor cell radiosensitivity was consistently reported, the radiosensitivity of normal fibroblasts was not affected by Hsp90 inhibition, suggesting the potential for tumor-selective radiosensitization. This review summarizes the preclinical data available on Hsp90 inhibition and cellular radiosensitivity. Results generated to date suggest that Hsp90 inhibition can provide a multitarget approach to tumor radiosensitization.Keywords
This publication has 30 references indexed in Scilit:
- Development of 17-allylamino-17-demethoxygeldanamycin hydroquinone hydrochloride (IPI-504), an anti-cancer agent directed against Hsp90Proceedings of the National Academy of Sciences of the United States of America, 2006
- Inhibition of homologous recombination repair in irradiated tumor cells pretreated with Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycinBiochemical and Biophysical Research Communications, 2006
- Inhibition of Hsp90 Compromises the DNA Damage Response to RadiationCancer Research, 2006
- Heat Shock Protein 90: A Unique Chemotherapeutic TargetSeminars in Oncology, 2006
- Hsp90α Recruited by Sp1 Is Important for Transcription of 12(S)-Lipoxygenase in A431 CellsJournal of Biological Chemistry, 2005
- Radiation-induced Epidermal Growth Factor Receptor Nuclear Import Is Linked to Activation of DNA-dependent Protein KinaseJournal of Biological Chemistry, 2005
- Rapid Glucocorticoid Receptor Exchange at a Promoter Is Coupled to Transcription and Regulated by Chaperones and ProteasomesMolecular and Cellular Biology, 2004
- Regulation of nuclear retention of glucocorticoid receptor by nuclear Hsp90Molecular and Cellular Endocrinology, 2003
- Geldanamycin, an inhibitor of Hsp90, sensitizes human tumour cells to radiationInternational Journal of Radiation Biology, 2003
- Evidence Supporting a Signal Transduction Pathway Leading to the Radiation-Resistant Phenotype in Human Tumor CellsBiochemical and Biophysical Research Communications, 1997